Replies to post #377942 on Elite Pharmaceuticals Inc (ELTP)

[jammy32]

What are your thoughts on why the stock is reacting poorly today? Was a good CC.

[kayak_wench]

I am keeping cash on had to have money to buy into that dip. It could be a pretty big dip given they can't seem to get quota in time to avoid any dip. If the news comes after a successful test of the generic Oxycontin has been announced the dip may not equal a low price compared to todays price. I think a successful insufflation study on the generic Oxycontin could give us a nice price boost if they mention not only that it was for a generic opioid extended release but also PRs the product's IQVIA reported annual sales.

[littlerhody]

Our CEO is a lot of things but his track record for projections on upcoming quarters have proven to be reliable. Agree, he would not have thrown that $40 million out there if he did not have something to hang his hat on.

[Just give me $1.50]

What the HELL are you talking about?

What aren't people factoring in the following with the Adderall sales?

1. Vigabatrin - Launching 2nd half of 2023.
2. Adderall IR - Launching in Israel this year.
3. Adderall IR/XR - Launching in another country in addition to Israel this year.
4. Dopamine Agonist - Launching FY2024 Q4.
5. Doxycycline - Launch to be determined.

He follows that up with the sales forecast for the entire year to be over 40 million.

To me that indicates the profit swing of selling it ourselves and that sales are already in place.